Ciclesonide

环索奈德

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameCiclesonide
Drug Alias NameCiclesonidumCiclenosideciclesonidaOsonaseOsonide +[19] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory HypersensitivityRhinitis, Allergic, Seasonal +[9] 
Global Approved IndicationsRhinitis, AllergicAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryAustralia
Original Approved Date2004/02/24
Country/TerritoryCzechiaBelgiumCanada +[33] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCovis Pharma GmbHUniversity Of PittsburghTeijin Pharma Ltd +[7] 
Inactive CompaniesCovis Pharma S.À.R.L.Sumitomo Pharma America IncSanofi +[9] 
Active IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, PerennialRhinitis, Allergic +[5] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory HypersensitivityRespiratory Tract Diseases +[4] 

Other Information

ATC CodeR01AD13R03BA08
Related LinksWikipediaDrugBankKEGG